The NHS has introduced a new vaccine to protect vulnerable groups from respiratory syncytial virus (RSV), a common but potentially dangerous winter infection. Starting today, the jab is being offered to adults aged 75 and over, as well as pregnant women, to reduce hospitalisations and severe illness.
Why This Vaccine Matters
RSV often causes mild cold-like symptoms but can lead to serious complications in older adults and infants. Each year, thousands are hospitalised, with the virus contributing to an estimated 14,000 deaths in over-75s annually in the UK.
Who Can Get Vaccinated?
- Adults turning 75 by 1 September 2024
- Pregnant women (to protect newborns)
- Those in care homes will be prioritised first
The rollout follows successful trials showing the vaccine is 82% effective at preventing lower respiratory tract disease caused by RSV.
What Experts Say
Professor Sir Stephen Powis, NHS national medical director, stated: "This new vaccine could be life-saving for our most vulnerable patients during winter months when RSV circulates widely."
The immunisation programme comes as part of the NHS's winter preparedness plan, alongside flu and COVID-19 vaccinations. Eligible individuals will be contacted by their GP or midwife in coming weeks.
